GnRHa

AcronymDefinition
GnRHaGonadotrophin Releasing Hormone Agonistic Analogue
References in periodicals archive ?
Exclusion criteria included: (1) Congenital hypothyroidism; (2) Peripheral precocious puberty: Germ cell tumors and various types of gonadal tumors; (3) Organic diseases including congenital adrenal hyperplasia, adrenal tumors, various intracranial tumors; (4) Precocious puberty resulted by central nervous system diseases; (5) Exogenous precocious puberty, such as medicines, hormones, or pollute; (6) Patient who had used corticosteroid within 3 months before enrollment; (7) ICPP patient who had used GnRHa.
Segun la literatura cientifica disponible, todos los GnRHa son efectivos cualquiera sea la presentacion, via de administracion y duracion de accion, siendo los preferidos, por su adherencia al tratamiento, las preparaciones de deposito (triptorelina) (7, 61).
GnRHa injection accelerates final maturation and ovulation/ spermiation of sockeye salmon (Oncorhynchus nerka) in both fresh and salt water.
Gonadotropin releasing hormone analogues (GnRHa) also have been used to stimulate milt production in salmonids, increased milt volume or accelerated production of milt has been observed in response to GnRHa treatment (Weil and Crim, 1983).
Progestins such as norethisterone acetate may be administered with or without addition of low doses of oestrogens to safely and effectively extend GnRHa therapy while minimizing side effects.
La inyeccion de GnRH o GnRHa, que puede ser administrada mediante implantes de liberacion lenta, induce un incremento inmediato en los niveles plasmaticos de GtH (gonadotropinas) en muchos peces por un corto periodo, durante el cual se debe activar la maduracion final de los oocitos, la espermiacion o la desova (Valdebenito, 2008).
Induction of ovulation in captivereared dusky grouper, Epinephelus marginatus (Lowe, 1834), with a sustained-release GnRHa implant.
While initial administration of GnRHa results in increased levels of circulating luteinizing hormone (LH) and follicle-stimulating hormone (FSH), continuous administration results in decreased secretion of LH and FSH from the pituitary gland to levels of a castrated man or menopausal woman (Skidmore-Roth, 2007).
using a GnRHa (Superfact, Ferring, Germany) and combination of HMG (Menogon, Ferring, Germany) or recombinant FSH (Gonal-F, Serono, Switzerland).
The team used a drug called GnRHa to stop the process of egg release and periods, effectively creating a temporary menopause.
Agonistas de la hormona liberadora de gonadotrofinas (GnRHa): la mejor evidencia de su utilidad se deriva de la revision sistematica del grupo Cochrane42 en 20 RCTs, que comparo los GnRHa con controles o placebo.